Literature DB >> 9618786

Control of the membrane sex hormone-binding globulin-receptor (SHBG-R) in MCF-7 cells: effect of locally produced SHBG.

N Fortunati1, M Raineri, A Cignetti, G L Hammond, R Frairia.   

Abstract

The interaction between plasma sex hormone-binding globulin (SHBG) and its receptor (SHBG-R) inhibits estradiol-induced proliferation of MCF-7 cells (human estrogen-dependent breast cancer) through cAMP and PKA. Thus, SHBG can modulate estradiol action in breast cancer, but the implications of this require a more detailed knowledge of the SHBG-R. To this end, we have transfected MCF-7 cells with an expression vector carrying the human SHBG cDNA (S-MCF-7) and studied the effects of this on both SHBG-R binding and cell proliferation. Control cells were parental MCF-7 (P-MCF-7) and MCF-7 cells transfected with the beta-galactosidase gene (B-MCF-7). Transfections were mediated by lipofectin followed by selection of transfected cells with G418. The amounts of SHBG in culture medium were evaluated by IRMA assay, with only S-MCF-7 cells shown to secrete SHBG; SHBG-R levels were evaluated by tracer binding technique. In P-MCF-7 and B-MCF-7 cells, SHBG-R was detectable as a two-binding site receptor, but no binding of SHBG was observed in S-MCF-7 cells. Proliferation of cells treated with estradiol was evaluated by [3H]thymidine incorporation in the three cell lines and in cells pretreated with SHBG (1 nM) purified from human serum or with conditioned medium from S-MCF-7 cells (medium S). In all three lines, cell proliferation increased after estradiol treatment. Preincubation with purified SHBG was effective in reducing estrogen-induced cell proliferation to basal levels in P-MCF-7 and B-MCF-7 but not in S-MCF-7 cells. The estradiol effect was also inhibited in P-MCF-7 cells treated with medium S. In conclusion, 1) SHBG inhibits estradiol-induced proliferation in cells containing a functional SHBG-R, whereas it has no detectable effect in cells in which the SHBG-R is either absent or not available to bind SHBG; and 2) S-MCF-7 cells are insensitive to SHBG (locally produced or exogenous) because their SHBG-R is occupied by SHBG.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9618786     DOI: 10.1016/s0039-128x(98)00021-x

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  6 in total

Review 1.  Sex hormone-binding globulin: not only a transport protein. What news is around the corner?

Authors:  N Fortunati
Journal:  J Endocrinol Invest       Date:  1999-03       Impact factor: 4.256

2.  Efficient eukaryotic expression system for authentic human sex hormone-binding globulin.

Authors:  J Hilpert; H Vorum; R Burmeister; R Spoelgen; I Grishkovskaya; R Misselwitz; A Nykjaer; T E Willnow
Journal:  Biochem J       Date:  2001-12-15       Impact factor: 3.857

3.  [18F]Fluorinated estradiol derivatives for oestrogen receptor imaging: impact of substituents, formulation and specific activity on the biodistribution in breast tumour-bearing mice.

Authors:  François Bénard; Naseem Ahmed; Jean-Mathieu Beauregard; Jacques Rousseau; Antonio Aliaga; Céléna Dubuc; Etienne Croteau; Johan E van Lier
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-03-13       Impact factor: 9.236

4.  What maintains the high intra-follicular estradiol concentration in pre-ovulatory follicles?

Authors:  Yaakov Bentov; Andrea Jurisicova; Shlomit Kenigsberg; Robert F Casper
Journal:  J Assist Reprod Genet       Date:  2015-11-09       Impact factor: 3.412

5.  Human sex hormone-binding globulin does not provide metabolic protection against diet-induced obesity and dysglycemia in mice.

Authors:  Yael Sofer; Nava Nevo; Michal Vechoropoulos; Gabi Shefer; Etty Osher; Nathan Landis; Karen Tordjman; Geoffrey L Hammond; Naftali Stern
Journal:  Endocr Connect       Date:  2017-11-15       Impact factor: 3.335

6.  Human sex hormone-binding globulin gene expression- multiple promoters and complex alternative splicing.

Authors:  Atif M Nakhla; Daniel J Hryb; William Rosner; Nicholas A Romas; Zhaoying Xiang; Scott M Kahn
Journal:  BMC Mol Biol       Date:  2009-05-05       Impact factor: 2.946

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.